P ulmonary vascular constriction and remodeling are integral traits of pulmonary hypertension, which results in increased resistance of pulmonary vasculature, failure of right heart, and ultimately death. A variety of environmental pathogenic factors, such as cigarette smoke, can cause pulmonary endothelial cell damage and proliferation of smooth muscle cell and lead to the development of pulmonary hypertension.
P ulmonary vascular constriction and remodeling are integral traits of pulmonary hypertension, which results in increased resistance of pulmonary vasculature, failure of right heart, and ultimately death. A variety of environmental pathogenic factors, such as cigarette smoke, can cause pulmonary endothelial cell damage and proliferation of smooth muscle cell and lead to the development of pulmonary hypertension. 1, 2 The increased pulmonary artery pressure after 1-month exposure to cigarette smoke, 2, 3 and the dissociation of pulmonary hypertension from emphysema, 1, 2 suggests that cigarette smoke can directly induce pulmonary hypertension independently of alveolar hypoxia resulting from emphysema or any other chronic obstructive pulmonary disease. The mechanisms underlying the direct effects of cigarette smoke on the pathophysiology of pulmonary hypertension, however, remain largely unknown.
Studies from our group and others have shown that cigarette smoke can induce the release of extracellular vesicles (EVs) from various cell type, [4] [5] [6] including vascular endothelial cells. 7, 8 EVs have the ability to carry various molecules derived from the parental cells on their surface or within their cytosol. 9 Circulating endothelial EVs (eEVs) constitute a biomarker of endothelium dysfunction correlating with the degree of pulmonary hypertension. 10, 11 However, the molecular processes underlying the effects of eEVs in the progressive development of pulmonary hypertension remain unexplored.
In our pilot studies on eEVs from smoking human subjects, the metabonomic analysis revealed a prominent increase in the content of spermine-a polyamine metabolite executing multiple biological activities as a potent agonist of the extracellular CaSR (calcium-sensing receptor). 12, 13 Considering the critical importance of CaSR in hypoxia-and monocrotalineinduced pulmonary hypertension as recently revealed from several laboratories, [14] [15] [16] [17] we designed the current preclinical study to explore the pathophysiological significance of eEVs and the spermine-CaSR pathway in cigarette smoke-induced pulmonary hypertension.
Methods
The authors declare that all supporting data are available within the article (and its online supplementary files).
Human Subjects
Ethical approval was obtained from the Ethics Committee of Tongji Medical College. Blood plasma samples of nonsmokers and smokers without pulmonary dysfunction were retrieved from outpatients of Union Hospital affiliated to Tongji Medical College, and all subjects provided written informed consent.
Cigarette Smoke Exposure, Delivery of Antagonist, and shRNA In Vivo
The experiments with Sprague-Dawley rats were authorized by the Institutional Animal Care and Use Committee of Tongji Medical College, performed under National Institutes of Health Guide for the Care and Use of Laboratory Animals with an estimation of the sample size to minimize the number of animals used. Male Sprague-Dawley rats at 6 weeks of age were allocated randomly to air exposure or cigarette-smoking groups as we described previously. 18 Briefly, 8 rats were caged in a 0.25-m 3 box and exposed either to a mixed air and smoke (12:1) of 10 cigarettes (each containing 16 mg tar and 1.0 mg nicotine; Hong Shuangxi Brand, Wuhan, China) or to fresh air, delivered by a ≈5.0-mL puff every 2 seconds for 1 hour, once a day for 35 days. The total suspended particle concentration and carbon monoxide level in the chamber was 509.46±63.97 and 1256.24±67.99 mg/ m 3 during smoke exposure, which resulted in an accumulation of nicotine and carboxyhemoglobin in rat blood at 55.35±8.78 ng/mL and 10.37±0.71% (n=5) similar to the levels in the blood of smokers. 19, 20 Calhex231, shRNA against CaSR, and nonspecific shRNA treatments were applied to control groups and smoke groups. Calhex231 treatment was intraperitoneally injected into rats at 80 μg/kg every day from day 1 to day 28. 15 For shRNA delivery, the oligo-DNA encoding effective and specific shRNA against CaSR and nonspecific control shRNA were packaged into a Lenti-X shRNA expression vector (Clontech) 72 hours before smoke or air exposure, and 1 mL lentivirus at about 10 8 transducing units was intravenously injected into rats according to our previous reports.
14 Subsequently, blind assessments were performed for all hemodynamic measures and morphological analyses. Animals that failed hemodynamic measure or tissue preparation for morphological analysis were excluded. The allocation was also concealed by blinded administration of treatments.
Preparation and Analysis of eEVs From Cultured Endothelial Cells
eEVs were isolated from cultured rat pulmonary artery endothelial cells (PAECs) following the procedures slightly modified from the previous reports. 21, 22 PAECs were seeded in 6 cm diameter culture dish at a density of 5×10 5 cells and cultured in endothelial cell growth medium-2, Lonza containing 5% standard fetus bovine serum (FBS, 10099-141; Invitrogen) for 24 hours. Then the cells were exposed to 1.0 mL fresh endothelial cell growth medium-2 supplemented with 5% FBS and 10% cigarette smoke extract (CSE). After a 24-hour coincubation with 10% CSE, the culture medium of PAECs (≈2×10 6 for each) was collected by centrifuging at 4500g at 4°C for 5 minutes, and the supernatant was centrifuged again at 100 000g at 4°C for 90 minutes. The pelleted eEVs were finally resuspended in 100 μL PBS. The lipoprotein (Apo-A1 and Apo-B) was ≈0.82% and 0.75% of the total eEV protein isolated from the vehicle or CSE-treated PAECs ( Figure I in the online-only Data Supplement). eEVs were also isolated from nonconditioned medium containing fresh endothelial cell growth medium-2 supplemented with 5% standard FBS and 10% CSE and from the medium of PAECs cultured with endothelial cell growth medium-2 supplemented with 5% exosome-depleted FBS (A2720803; Invitrogen) and 10% CSE.
The quantitative analysis of eEVs was performed by flow cytometry as described previously. 23 The 100 μL eEV suspension was split into 2 aliquots. Forty microliters suspension was aspirated from 1 aliquot and incubated with fluorescein isothiocyanate (FITC)-conjugated anti-CD31 antibody (10 μL, 1 μg, ab33858; Abcam Biosciences) and phenylephrine-conjugated anti-CD42b antibody (10 μL, 10 μg, bs-2347R-phenylephrine; Bioss) in a dark room for 30 minutes. Then, 40 μL microsphere beads (F8819; Invitrogen) were added into the suspension at a final density of 1011 microparticles per microliter to determine the numbers of eEVs in samples. The eEVs were continuously counted on a Cytomics FC500 Flow Cytometer (Beckman Coulter, IN) until the counting of microsphere beads reached 10 000 events for each sample, and the extracellular vesicle gate was set at <1 μm with the side scatter voltage and forward scatter one at 346 and 220 V, respectively. The number of CD31 + /CD42b
− eEVs was calculated following the formula: eEVs, R1/R2×1011/μL; R1 and R2 were the percentage of CD31 + /CD42b − eEVs and standard beads out of the total EVs. Fifty microliters eEV suspension of PAECs was sonicated for the extraction and concentration determination of protein by spectrophotometry according to the previous studies. 24 
Preparation and Analysis of EVs From Blood
EVs were isolated from rat and human blood plasma following a protocol modified from previous studies. 26, 27 Two milliliters whole blood from each rat or person was collected in the sodium citrate anticoagulation tube and subsequently centrifuged at 1500g at room temperature for 10 minutes. The aspirated blood plasma was then centrifuged at 15 000g at 4°C for 10 minutes to remove platelet; then the plateletfree plasma was centrifuged again at 100 000g at 4°C for an additional 90 minutes. The pelleted EVs were finally resuspended in 100 μL PBS. The lipoprotein was ≈12.00% and 8.32% of the total EV protein isolated from blood of air-or smoking-exposed rats ( Figure I in the online-only Data Supplement).
The quantitative analysis of eEVs was performed by the same flow cytometry using FITC-conjugated anti-CD31 antibody (10 μL, 1 μg, ab33858 for rat, ab27333 for human; Abcam Biosciences) and phenylephrine-conjugated anti-CD42b antibody (10 μL, 10 μg, bs-2347R-phenylephrine for rat and human; Bioss), as well as the microsphere beads (F8819; Invitrogen). In separate experiments, the pelleted EVs from 2 mL whole blood of each rat or person were resuspended in 50 μL PBS and subjected to flow cytometry to monitor nonspecific labeling and to calibrate the level of CD31 + /CD42b − eEVs as described above.
For the recovery of CD31 + /CD42b − eEVs from rat and human blood, the EV from 8 mL whole blood of each rat or person was isolated following the above procedures and finally resuspended in 80 μL PBS. The EV suspension was incubated with the above antibodies against CD31 and CD42b in a dark room for 30 minutes and then immediately sorted by FACSAriaIII flow cytometer (BD Biosciences, San Jose, CA), which equipped by 4 independent lasers with the excitation wavelength of 488 nm and emission wavelength of 520 or 578 nm used for FITC and phenylephrine, respectively. The extracellular vesicle gate was set at <1 μm with the side scatter voltage and forward scatter 1 at 346 and 220 V. A 70-μm nozzle was used, sheath fluid pressure was 30 psi, and sample fluid pressure was 29 psi. The sorting efficiencies were about 96%. The sorted eEVs and other EVs were collected in clean polypropylene tubes, and part of eEVs was analyzed on the same settings to identify their purities (95.49±1.34% and 96.09±0.70% for rat and human; n=5 for each).
For the preparation of eEVs from human blood for functional tests ( Figure V in the online-only Data Supplement; Table III in the online-only Data Supplement), the pelleted EVs were resuspended in 100 μL PBS, then 40 μL was aspirated and subjected to flow cytometry for the quantitative determination of CD31 + /CD42b − eEVs level, which was used for the adjustment of CD31 + /CD42b − eEV density in the remaining EV suspension before the final application.
Hydrophilic Interaction Chromatography, Ultra High-Performance Liquid Chromatography-4-Flight Time Series Mass Spectra Analysis
The metabolite changes in eEVs isolated from plasma were analyzed by hydrophilic interaction chromatography, ultra high-performance liquid chromatography (HPLC)-4-flight time series mass spectra as follows. The eEV pellets were mixed with 200 μL precooling methanol/acetonitrile aqueous solution (2:2:1, v/v) by vortex and ultrasound pyrolysis at 4°C for 30 minutes. After 10 minutes of cooling at −20°C, the mixed solution was centrifuged for 20 minutes at 4°C at 14 000g. The supernatant was then aspirated and added into a fresh 2-mL glass vial (GC/MS) and rotated in a vacuum evaporator to dry. After being mixed with 100 μL aqueous solution of acetonitrile (v:v at 1:1) by vortex and centrifuged again for 20 minutes at 4°C at 14 000g, the final supernatant was recovered for the subsequent liquid chromatography-mass spectrometry analysis.
HILIC chromatographic column (Agilent 1290) was flushed with 30 mL distilled water and equilibrated with 30 mL of the mobile phase containing 5% phase A and 95% phase B at 0.3 mL/min, 25°C before the injection of the recovered supernatant, and the sample was consecutively separated with the linear gradients containing phase B at 95% for 0 to 1 minute, from 95% to 65% for 1 to 14 minutes, from 65% to 40% for 14 to 16 minutes, 40% for 16 to 18 minutes, from 40% to 85% for 18 to 18.1 minutes, and 85% for 18.1 to 23 minutes. The phase A mobile was water with 25 mmol/L ammonium hydroxide and 25 mmol/L ammonium acetate and the phase B mobile was acetonitrile.
The subsequent MS analysis was performed on a Triple time of flight (TOF) 6600 (AB SCIEX) connected to an electrospray ionization source both in negative and positive ion modes. The electrospray ionization was run at the voltage floating of ±5500 V with the TOF MS scan m/z range between 60 and 1000 Da, the range of product ion scan m/z at 25 to 1000 Da, the accumulation time of TOF MS scan at 0.2 s/spectra, and the accumulation time of product ion scan on 0.05 s/spectra. The tandem MS was conducted by information-dependent acquisition with the declustering potentials at ±60 V and collision energy of 35±15 V.
High-Performance Liquid Chromatography
EVs (10 6 ) from rat blood plasma, 10 7 eEVs from PAECs, or 10 6 PAECs suspended in 800 μL PBS were broken by ultrasonication, mixed with 600 μL of ice-cold 10% perchloric acid, and maintained for 60 minutes on ice and then centrifuged for 30 minutes at 4°C at 15 000g. The supernatant was decanted into another centrifuge tube, mixed with 10 μL of benzoyl chloride and 500 μL of 2 M NaOH for the 30 s by vortex, and incubated for 20 minutes at 37°C; 2 mL saturated NaCl was then added to end the reaction. After thoroughly mixing, 2 mL diethyl ether was added, and the mixture was centrifuged for 5 minutes at 450g. The supernatant was collected and evaporated in nitrogen gas; the resulting deposit was dissolved in 100 μL methyl alcohol and filtered through 0.22 μm filter, 50 μL of filtrate being used for HPLC analysis. The samples were eluted by a gradient mixture of methanol (55%-74% from 0 to 14 minutes and 74% from 14 to 24 minutes) 28 and water at a 1.0-mL/min of flow rate on a Water Chromatography System (Waters 1525) with a C18 column (5 μm, 250×4.6 mm id, Kromasil) and UV detector (Waters 2487). The temperature of the column was kept at 40°C, and the injection volume was 10 μL. The accuracy of spermine in samples was identified by the retention time of authentic standards of spermine at 245 nm. A series of standard spermine solution of different concentrations (5, 10, 50, 100, 500, and 1000 ng/mL) was prepared for the generation of the standard curve and the subsequent calibration of spermine contents in each sample.
eEV Injection In Vivo
eEVs (2×10 7 , suspended in 1 mL PBS) isolated from PAECs treated with CSE (eEV_CSE) or other conditions were injected into rats via tail vein every other day. The time interval for repetitive injection was determined according to the halftime for eEV clearance from blood plasma, estimated in pilot experiments to be ≈49 hours by the sequential monitoring of eEV contents in blood after an intravenous administration of eEVs.
Statistical Analysis
All results were reported as mean±SEM. When normality test (Shapiro-Wilk) passed and equal variance test passed, 1-way ANOVA (Fisher LSD method) was conducted for multiple-group comparisons and Student t test for 2-group comparisons; when normality test (Shapiro-Wilk) passed and equal variance test failed, 1-way ANOVA (Dunnett method) was conducted for multiple-group comparisons and Mann-Whitney rank-sum test for 2-group comparisons; if normality test (Shapiro-Wilk) failed, Kruskal-Wallis 1-way ANOVA on ranks (Dunn method) was performed for multiple-group comparisons. Significant differences in statistics were indicated by P <0.05.
All the details about our hemodynamic studies and morphological assays, 16 17 and CaSR knockout rats 14 preparation have been provided in the online-only Data Supplement and fully described in our previous studies. 14, [16] [17] [18] 29, 30 
Results

Cigarette Smoke-Induced Pulmonary Hypertension Bypass Chronic Hypoxia Was Associated With CaSR
A 5-week exposure to cigarette smoke significantly increased mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), the Fulton index, and pulmonary artery wall thickness (PAWT) as compared with control rats ( Figure 1A through 1E). The rats showed no hypoxemia or emphysema ( Figure II in the online-only Data Supplement), we thus adopted the animal model in the current study to explore the primary mechanism underlying cigarette smoke-induced direct activation or injury of endothelial cells in the onset of pulmonary hypertension bypass chronic hypoxia.
In our exploratory study seeking potential candidate(s) for mechanistic mediator with eEVs prepared from the blood of human smokers using biomarkers of CD31 + CD42b − , 31, 32 metabonomic screen identified the most prominent increase in contents for spermine, spermidine, and their synthetic substrate, ornithine (by >4.38-, 1.72-, and 2.20-fold over nonsmokers; Tables I and II in the online-only Data Supplement). We excluded inosine (with 7.26-fold increase in its content; Tables I and II in the online-only Data Supplement) because of its protective potential as a modulator in pulmonary hypertension. 33 Our liquid chromatography-mass spectrometry, however, did not detect any spermine or spermidine in human plasma. Considering the most potent ability of spermine among polycationic CaSR agonists, 12, 13 we performed an intraperitoneal injection of Calhex231 and found that this CaSR antagonist significantly attenuated the development of pulmonary hypertension (mPAP, 21.20±0.37 mm Hg; PVR, 214.79±8.87 mm Hg·min/L; Fulton index, 0.29±0.01; and PAWT, 22.34±0.66%, n=5; P<0.05 versus cigarette smoke exposure rats for each; Figure 1A through 1D ). An intravenous injection of shRNA to knockdown CaSR expression 14 induced a similar inhibition of cigarette smoke-induced pulmonary hypertension ( Figure 1A through 1D ).
Cigarette Smoke Increased eEV Generation and Spermine Content in Rats In Vivo
In the subsequent experiments with rats, our flow cytometry identified more eEV generation from the blood of cigarette smoke-exposed rats than controls (Figure 2A) , with an average of ≈960 eEVs/µL close to the level in the blood of human smokers (1138±94 and 369±38 eEVs/µL for smokers and nonsmokers; n=11 for each). By HPLC, we quantified a >3-fold increase in spermine carried by the eEVs isolated from cigarette smoke-exposed rats compared with controls (6.03±0.50 versus 1.99±0.33 ng/10 6 eEVs, n=5; P<0.05; Figure 2B ). However, we did not detect any significant increase in the content of spermine in other types of EVs from the blood of cigarette smoke-exposed rats ( Figure 2B ). These results constitute the first observation that eEVs carry spermine and that cigarette smoke increased spermine level specifically in eEVs, not in any other type(s) of EVs in the blood.
CSE Increased eEV Generation and Spermine Content In Vitro
A 24-hour exposure to 10% CSE significantly increased the quantity of eEVs in the supernatant of cultured PAECs ( Figure 3A )-a process unaffected by the EVs in FBS of the culture medium because there was no difference in CSEstimulated eEV amount from PAECs cultured with standard FBS as compared with exosome-depleted FBS ( Figure III in the online-only Data Supplement). CSE exposure caused a larger accumulation of spermine within both the PAECs (914.57±45.70 versus 370.18±67.41 ng/10 6 cells for vehicle control, n=5; Figure 3B ) and eEVs (3.95±0.44 versus 1.74±0.12 ng/10 6 eEVs for vehicle control; Figure 3C ). Difluoromethylornithine (DFMO)-the irreversible inhibitor of ornithine decarboxylase, which serves as the rate-determining enzyme for of polyamine and spermine synthesisobviously dampened the CSE-increased spermine levels (585.69±29.78 ng/10 6 cells, n=5; P<0.05 versus PAEC treated with CSE alone, Figure 3B and 2.85±0.18 ng/10 6 eEVs, n=5; P<0.05 versus eEVs from PAEC treated with CSE alone, Figure 3C ) but did not decrease eEV release from PAECs ( Figure 3A) . The transduction of PAECs with an adenovirus encoding a key polyamine catabolic enzyme, spermidine N 1 -acetyltransferase 1 (SAT1, Ad SAT1), 34 led to a profound depletion of spermine in both PAECs (72.49±8.96 ng/10 6 cells after CSE treatment, n=5; Figure 3B ) and eEVs (0.68±0.06 ng/10 6 eEVs after CSE treatment, n=5; Figure 3C ). The overexpression of spermine synthase (SpmS OV) significantly increased spermine content as compared with vector overexpression (vector OV) in both PAECs (634.81±29.24 ng/10 6 cells, n=5; P<0.05 versus 329.35±44.94 ng/10 6 cells for vector OV; Figure 3B ) and eEVs (2.75±0.28 ng/10 6 eEVs, n=5; P<0.05 versus 1.70±0.32 ng/10 6 eEVs for vector OV; Figure 3C ). The quantification of spermine content using an alternative technique, the dicationic perylene probe-N 1 -dodecyl-N 3 -(4-phenyl) benzimidazolium-functionalized perylenediimide, 35 a novel chemical fluorescent probe confirmed the above changes measured by HPLC ( Figure IV in the online-only Data Supplement). Immunocytochemical staining and confocal microscopy demonstrated an increased amount of spermine-positive eEVs surrounding CSE-exposed PAECs compared with nontreated cells ( Figure 3D ) and interestingly displayed the wrapping or distribution of spermine on the outer surface of the plasma membrane of eEVs ( Figure 3D , the red and yellow arrow for complete and partial wrapping, respectively). Confocal images of immunocytochemical staining on isolated eEVs on coverslips confirmed the complete, partial wrapping of spermine on the outer surface of the plasma membrane of eEVs and the distribution of spermine only within eEVs ( Figure 3E ). Furthermore, immunogold electron microscopy showed apparently more EM contrast dots within the cytosol of eEVs (white arrow) and likely on the surface of plasma membrane of eEVs (black arrow) from CSE-exposed PAECs ( Figure 3F , middle left), which were fewer and only present in the cytosol of eEVs from vehicleexposed PAECs ( Figure 3F, left) , completely absent in eEV staining control without incubation of colloidal gold-labeled IgG ( Figure 3F , right) or dim in eEVs from PAECs treated with CSE and DFMO ( Figure 3F , middle right). These results not only confirmed the increased abundance of spermine within the cytosol of eEVs, the unexpected finding of spermine distribution on the outer surface of eEVs membrane, but also implied a novel paracellular or intercellular mode of spermine carried by eEVs, with the direct interaction with its target, such as CaSR on the membrane of neighborhood cells. Figure 4A ). eEV_CSE at 1000/μL, the concentration equal to the eEV level in circulating blood of cigarette smoke-exposed rats ( Figure 2) and similar with the current study and previous reports in human smokers 31, 32 Figure 4A ). The reduced [Ca 2+ ] i elevation at high doses of eEVs (≥3000 per µL) may be related with the inhibitory effect of intracellular spermine uptaken from extracellular space at this situation on phospholipase C and inositol 1,4,5-triphosphate receptor activity. 36, 37 As shown in Figure 4B and Figure VI in the online-only Data Supplement, eEVs obtained from PAECs without CSE treatment (eEV_ vehicle; n=21) or EVs isolated from nonconditioned medium (EV_NCM, only ≈2.12% and 1.07% of the total eEVs from vehicle or CSE-exposed PAECs; n=5) did not arouse [Ca 2+ ] i signaling (n=22); eEVs isolated from CSE-treated PAECs in the presence of DFMO (eEV_CSE_DFMO) or from SAT1-expressed PAECs (eEV_CSE_Ad SAT1) after CSE exposure, which carried less amount of spermine ( Figure 3C) 
eEVs Triggered Pulmonary Artery Smooth Muscle Constriction and Proliferation Mainly Through Spermine/CaSR Pathway
In endothelium-removed pulmonary artery (PAs) rings as confirmed by the absence of acetylcholine-triggered relaxation in phenylephrine preconstricted preparations, the exposure of eEV_CSE at 1000/μL increased tension from resting level to >60% of 80 mmol/L K + (KCl-physiological salt solution)-induced response (64.79±8.31% and 63.25±4.90% for the first and second challenge; Figure 5A ). As also shown in Figure 5A and Figure for the first and second challenge of eEVs; P<0.05 versus control shRNA).
As shown in Figure 5B and Figure VIIb in the online-only Data Supplement, a 24-hour exposure of eEV_CSE, not eEV_ vehicle or EV_nonconditioned medium, stimulated a rapid growth in PASMCs; eEV_CSE_DFMO exerted a weakened ability, and eEV_CSE_Ad SAT1 failed, to cause an increase in PASMC growth; both eEV_SpmS OV and spermine, however, enhanced PASMC growth; N 1 -dansyl-spermine, Calhex231, and CaSR knockdown in PASMCs inhibited this growth response to a large extent.
In separate experiments, a 24-hour exposure of eEV_ smoker, not eEV_nonsmoker, stimulated rapid growth of human PASMCs ( Figure V in the online-only Data Supplement). ] i in pulmonary artery smooth muscle cells (PASMCs) in response to vehicle (PBS; n=35) or a series of concentrations of eEVs prepared from 10% CSE-treated PAECs (eEV_CSE) at 300/μL (n=19), 1000/μL (n=19), 3000/μL (n=17), and 10 000/μL (n=24), and average [Ca 2+ ] i levels at baseline and peak (*P<0.05 vs vehicle). B, Representative curves of [Ca 2+ ] i response to 1000/μL eEV_CSE (n=19) or eEVs isolated from PAECs treated with vehicle (eEV_vehicle; n=21); to EVs prepared from nonconditioned medium (EV_NCM; n=22); to 1000/μL eEVs from SAT1-expressed pulmonary artery endothelial cells (PAECs; eEV_CSE_Ad SAT1; n=25) or its control PAECs (eEV_CSE_Ad control; n=18) after CSE exposure; to 1000/μL eEVs prepared from spermine synthase-(eEV_ SpmS OV; n=17) or vector-overexpressed PAECs (eEV_vector OV; n=20); or to 1000/μL eEV_CSE in CaSR specific shRNA-(n=28) or control shRNA (n=16)-treated PASMCs; and average [Ca 2+ ] i levels at baseline and peak (*P<0.05 vs eEV_vehicle; #P<0.05 eEV_CSE alone.
eEVs thereby appeared to cause pulmonary vasoconstriction and proliferation of PASMCs mainly through spermine/ CaSR signaling pathway.
Cigarette Smoke-Induced eEV Migration Into Smooth Muscle Cells
As shown in Figure 6 , the distinct distribution fluorescence (purple) of CD63-a general marker of EVs-in the pulmonary artery in smoke rats versus the dim fluorescence of CD63 in control rats indicated cigarette smoke-induced accumulation of EVs in the pulmonary artery ( Figure 6A, left) . Additionally, the quantitative analysis estimated that the fluorescence overlap of CD63 (purple) and CD31 (cyan) accounted for ≈76.96±3.16% of the total fluorescence of CD63 ( Figure 6A . Extracellular vesicles (eEVs) stimulated spermine-and extracellular calcium-sensing receptor (CaSR)-dependent pulmonary artery smooth muscle vasoconstriction and proliferation. A, Isometric tension of endothelium-removed and phenylephrine (PE; 0.1 μM)-preconstricted pulmonary artery rings (PAs) in response to acetylcholine (Ach;10 μM), then to the 2 successive episodes of 1000/μL eEVs isolated from PAECs treated with cigarette smoke extract (CSE; eEV_CSE) and finally to 80 mmol/L K + KCl-physiological salt solution (KPSS) or to the first episode of 1000/μL eEV_CSE and the second one of 1000/μL eEVs from PAECs treated with vehicle (eEV-vehicle) or to the first episode of 1000/μL eEV_CSE and the second one of EVs prepared from nonconditioned medium (EV_NCM); or to the first episode of 1000/μL eEV_CSE and the second one of 1000/μL eEVs from SAT1-expressed PAECs (eEV_CSE_Ad SAT1) or its control PAECs (eEV_CSE_Ad control) after CSE exposure; or to the first episode of 1000/μL eEV_CSE and the second one of 1000/μL eEVs prepared from spermine synthase-(eEV_SpmS OV) or vector-overexpressed PAECs (eEV_vector OV); isometric tension of endothelium-removed and PE-preconstricted PAs isolated from CaSR shRNA and control shRNA-treated rats in response to Ach, then to the 2 consecutive episodes of 1000/μL eEV_CSE; and the averaged responses normalized to KPSS-induced response for each separate experiment, *P<0.05, n=4 for each. B, The pulmonary artery smooth muscle cell (PASMC) proliferation assay after a 24 h exposure to vehicle, eEV_CSE or eEV_vehicle, EV_NCM, eEV_CSE_Ad SAT1, or eEV_CSE_Ad control, eEV_SpmS OV or eEV_vector OV, or eEV_CSE in CaSR shRNA and control shRNA-treated PASMCs (*P<0.05 vs vehicle, #P<0.05 vs eEV_CSE), n=4 for each.
spermine with α-actin ( Figure 6A, right) . These results thus suggested that spermine is mainly carried by CD31 + -EVs to reach smooth muscle cells in pulmonary artery in smoke rats.
The above stainings, however, cannot determine the tissue or cellular resource of CD31 + -EVs in pulmonary artery because CD31 is expressed also by leucocyte subsets and activated platelet. The CD31 + /CD42b
− and CD31 + /CD42b + were, therefore, used in the subsequent stainings to define the eEVs and the EVs derived from other source(s) rather than endothelium. As also shown in Figure 6 , smoke exposure slightly increased CD42b fluorescence in pulmonary artery of rats versus the absence in control ( Figure 6B, left) ; the overlap fluorescence of CD31 (cyan), CD42b (purple), spermine (red), and smooth muscle-specific α-actin (green), however, + EVs (derived from another source rather than endothelium) carry a small portion of spermine to reach smooth muscle cells of pulmonary arteries, leaving the majority of spermine at ≈83% to be carried by CD31 + /CD42b − EVs, the eEVs. Together with the estimation that the overlap of CD31 + -EVs spermine with α-actin constitutes ≈80% of the total overlapped fluorescence of spermine with α-actin ( Figure 6A ), eEVs may carry >66% of the total spermine that reached smooth muscle cells of PAs after smoke exposure.
Collectively, the above findings suggest that spermineloaded eEVs may migrate from the endothelium toward the smooth muscle cells in PAs exposed to cigarette smoke; spermine-loaded EVs from other sources rather than endothelium may also contribute to the transfer of some spermine.
Spermine/CaSR Signaling Pathway Mediated eEV-Induced Pulmonary Hypertension
As shown in Figure 7A 
Discussion
The rationale for the current study was the finding of an increased amount of spermine enriched in eEVs isolated from the blood of human cigarette smokers, as well as from cigarette smoke-exposed rats. The resultant concealment or anchoring of spermine within eEVs and the low level of spermine in blood plasma, undetectable by routine biochemical techniques, may be among the reasons for a previously ignored pathophysiologic pathway in cigarette smoke-induced pulmonary hypertension.
The cigarette smoke-induced enrichment of spermine within eEVs occurred mainly because of enhanced synthesis in endothelial cells as DFMO-the inhibitor of a rate-limiting enzyme for spermine synthesis (ornithine decarboxylase)-decreased spermine content in CSE stimulated-endothelial cells and eEVs (Figure 3 ). Although knowledge of cigarette smoke-induced alterations of polyamine metabolism is limited, the above conclusion may be supported by previous studies in other types of lung cells or tissues. Indeed, CSE increased the activity of ornithine decarboxylase in rat trachea 38 and the content of s-adenosylmethionione-a donor of spermine synthesis in human lung epithelial-like cells. 39 The pathophysiologic role of spermine may be different in other organs because it was shown that CSE induced an inhibitory action on ornithine decarboxylase activity and polyamine synthesis in gastric mucosa. 40 The cellular content of spermine highly varies from 0.5 nmol to 2 μmol per 10 6 cells in different cell types. 41, 42 In this study, basal cellular level of spermine in PAEC is about 1.5 to 2.0 nmol per 10 6 cells. Considering the PAEC volume of ≈2000 fL 43 and eEV diameter determined by electronic microscopy of this study, the formation of eEVs resulted in a huge enrichment of spermine concentration within their cytosol by a >100-fold increase than the whole cytosolic concentration. Based on the size of eEVs and spermine content measured by HPLC, spermine accumulated at an estimated concentration of ≈4.2 to 5.4 mmol/L within the cytosol of control eEVs without cigarette smoke or CSE exposure. Cigarette smoke or CSE exposure further increased the spermine content within the cytosol of eEVs ≈10.9 to 13.6 mmol/L. Facing the fact that the active concentration of spermine in the solution is around the high micromolar and low millimolar range as previously reported 13, 15 and confirmed in the current study (Figures 4 and 5) , the failure of control eEVs prepared from PAECs without CSE exposure in inducing Ca 2+ signaling or downstream events indicates that the high level of spermine alone is not the sole reason for the potent activities of eEVs isolated from CSE-treated PAECs, even though they work in an intercellular manner locally. An additional contribution is the quantity of eEVs in blood increased by ≈5-fold after cigarette smoke exposure (Figure 2) . Although eEV-mediated intercellular communication between PAECs and PASMCs has been reported to be a potential mechanism underlying the development of pulmonary hypertension, 44, 45 one interesting finding of the current study is the enhanced enrichment of spermine on the outer surface of eEVs formed from CSEexposed PAECs (Figure 3 ). This may provide a novel mechanistic presumption for promoting the effective adhesion of eEVs on and even further fusion of eEVs with smooth muscle cells through spermine-CaSR interaction. Thus, increased spermine distribution on the outer surface of eEVs membranes, a larger amount of spermine enriched within eEVs, and increased quantity of eEVs in blood after cigarette smoke or CSE exposure synergistically contribute to inducing Ca 2+ signaling and downstream events in smooth muscle cells.
Although our results strongly suggest a pathophysiologic role of the spermine-CaSR pathway mediated by eEVs bridging the endothelium and smooth muscle cells in cigarette smoke-induced pulmonary hypertension, failure of DFMO treatment to completely abolish eEV-induced pulmonary hypertension in CaSR −/− PTH −/− rats suggests other mechanisms beyond the spermine-CaSR cascade. Additionally, even though spermine in vivo effect appears mediated by >66% through eEVs trafficking from endothelium to underlying smooth muscle (Figure 6 ), this does not rule out the possibility that in vivo, spermine effect might also be mediated by free spermine, unbound to extracellular vesicles. Furthermore, the animal model adopted in the current study is a relatively short-term cigarette smoke exposure-induced pulmonary (PVR; B) , the Fulton index (C), representative HE stainings, and summary of pulmonary artery wall thickness (D) in rats injected with vehicle (control), eEVs from PAECs treated with CSE (eEV_CSE), eEVs from PAECs treated with vehicle (eEV_vehicle), eEVs from PAECs treated with CSE and DFMO (eEV_CSE_DFMO), eEVs from PAECs treated with DFMO (eEV_DFMO), eEVs from SAT1-expressed PAECs (eEV_CSE_Ad SAT1) or its control PAECs (eEV_CSE_Ad control) after CSE exposure, eEVs prepared from spermine synthase-(eEV_SpmS OV) or vector-overexpressed PAECs (n=5-8 for each; *P<0.05). The injection of vehicle (control), eEV_CSE, and eEV_CSE_DFMO-induced alterations of mPAP (E), PVR (F), the Fulton index (G), and pulmonary artery wall thickness (H) in CaSR +/+ PTH −/− and CaSR −/− PTH −/− rats (n=6-7 for each; *P<0.05).
hypertension, 2,3 preceding the occurrence of chronic hypoxemia or emphysema usually seen after long-term exposure alone or in combination with lipopolysaccharides. This was indeed confirmed by the normal oxygen partial pressure of arterial blood and pulmonary alveoli structure ( Figure I in the online-only Data Supplement). Consequently, our findings relate to the early stages of cigarette smoke-induced lung injury with direct activation or damage of endothelium and the subsequent impact on smooth muscle cells in the development of pulmonary hypertension. In human smokers with normal lung function and partial pressure of arterial oxygen, independent studies demonstrated smooth muscle cell proliferation and extracellular matrix deposition in the thickened pulmonary vessel wall, 46, 47 suggesting the origination of pulmonary vascular remodeling at an earlier stage of cigarette smoke-induced respiratory disease, before the development of hypoxia. Whether the processes proposed from our study are still operative in the presence of longer exposure with hypoxia and obstructive lung disease remains to be established. Nevertheless, the potential role of polyamine in hypoxic pulmonary hypertension has been documented in previous studies 48 suggesting that this pathway is still operative in the presence of hypoxia. 
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